Multinational fresh food grower and distributor Camposol has unveiled a new biotechnology facility designed to support its initiatives to expand proprietary blueberry genetics.
Earlier this year, the company said it wants to replace almost 50% of its blueberry fields and increase production in the coming years.
The 21,500-square-foot facility, located in Chao, Virú (Trujillo), Peru, integrates both in vitro and ex vitro propagation within a single space and has an annual production capacity of up to 5 million blueberry plants.
Camposol states that the in vitro area will focus on plant development and propagation, using both conventional methods and bioreactors, as well as traditional (non-GMO) breeding techniques.

For the ex vitro phase, the facility’s growth chamber technology precisely controls temperature, humidity, CO₂, and lighting to optimize acclimatization and ensure seedlings adapt before transfer to nurseries and production fields.
The CEO of Camposol, Ricardo Naranjo, said the new building’s plans give the company “a strategic advantage” on the path to developing and multiplying new fruit proprietary varieties.
“With this new infrastructure, we strengthen our position as a solid, innovative agro-industrial company that is prepared to continue growing in a sustainable manner,” Naranjo said. “It gives us independence and the ability to ensure the availability of the plants needed to execute our strategic expansion and consolidation plan.”
*Photos courtesy of Camposol
Related stories:
Camposol anticipates early volumes for the 2024-25 blueberry season
Subscribe to our newsletter